Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes
oleh: Jing-Yi Hu, Hai-Lan Zou, Yan-Hua Li, Dong-Ying Nie, Chen Chao, Jin-Han Liu, Jin Ding, Zhi-Guang Zhou, Yang Xiao, Ning-Ning Wang
| Format: | Article |
|---|---|
| Diterbitkan: | Wolters Kluwer 2021-09-01 |
Deskripsi
No description available for this item.